Skip to content

Peer Support for Women With Heart Disease: Women@Heart

Cluster Randomization Trial of Peer Support for Women With Heart Disease: Women@ Heart

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03286010
Enrollment
180
Registered
2017-09-18
Start date
2018-01-01
Completion date
2024-06-17
Last updated
2024-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease, Women's Health

Brief summary

Women with heart disease are more likely to die or suffer another cardiac event or stroke within 5 years of an index event compared to men. They are also more likely to suffer depression and report lower quality of life. Cardiac Rehabilitation programs have been designed to address these issues, but most women do not attend. Women indicate they have a greater need to talk about their experiences with heart disease and seek social support to help them cope. Peer support, the assistance provided by other women with a similar illness experience, may be one way to enhance social support for women with heart disease and help them improve their psychosocial well-being. The Investigators have developed a peer support program called Women@Heart (W@H). The program is led by trained peer leaders (women who themselves have made a successful recovery from a heart event). A pilot test of the program showed promising results. The Investigators now need to conduct a more rigorous evaluation of the program. The main objective of this project is to determine if the W@H program helps women to improve their psychosocial well-being compared to being on a waiting list to participate in the program. It will also examine the effect of the program on: health behaviours (tobacco smoking, physical activity, sedentary behaviour, fruit and vegetable consumption, and medication adherence); coronary risk factors; and clinical outcomes (re-hospitalization, health care system use, death).

Interventions

BEHAVIORALWomen@Heart Program

The Women@Heart program is taught by trained peer leaders. Session content is focused on: emotional support (sharing your story, road to recovery, exploration of feelings, coping with changes, emotional management, coping with distress, effective communication, empowerment); informational support (self care behaviours, risk factor education and management, health care system and community resource navigation); and appraisal support (goal setting, action planning, problem solving, relapse prevention). In total there are 12-biweekly sessions offered over a 24-week period.

Sponsors

Ottawa Heart Institute Research Corporation
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Women who have been hospitalized at UOHI in the past year with stable CHD, including: AMI; stable angina with corroborating evidence of CHD; recent CABG; or percutaneous coronary intervention (to allow examination of mechanisms linking the intervention and psychosocial well-being with health and healthcare outcomes); 2. Women ≥ 18 years of age (the age of consent in Ontario); 3. Women able to read and understand English or French; 4. Women who reside in Ontario and are eligible for Ontario Health Insurance Plan (to permit linkage with administrative data housed at the Institute for Clinical Evaluative Sciences \[ICES\]); 5. Women available to participate over the next 6 months (the intervention and data collection takes place over this time frame -- reducing the probability of missing data); 6. Women able to provide informed consent.

Exclusion criteria

1. Women who have been hospitalized primarily for valve replacement or repair, HF, pulmonary hypertension, endocarditis or pericarditis (to reduce heterogeneity and avoid confounding when examining mechanisms linking the intervention and psychosocial well-being with health and healthcare outcomes); 2. Women who, in the opinion of the UOHI clinical psychologist, manifest psychiatric illness or cognitive impairment that would preclude participation in W@H (i.e. they are unable to benefit from the intervention, to prevent disruption of other participants).

Design outcomes

Primary

MeasureTime frameDescription
Psychosocial well-being as measured by a total composite scoreBaseline to week 26 follow upThe composite score will combine data from seven measures (ESSI, BCI, BAI, BDI2, MCS, HeartQol and PSS)

Secondary

MeasureTime frameDescription
Fruit/Vegetable consumptionBaseline to week 26 follow upMeasured by two questions from the Ontario Health Study that assess typical daily servings of fruits and vegetables.
Menstrual StatusBaseline to week 26 follow upMeasured through self reported menstrual status (i.e., pre, peri or post-menopausal)
Gender Role IdentityBaseline to week 26 follow upThe BEM Sex Role Inventory will be used to assess participants' feelings towards their own gender role identities (masculine, feminine, androgynous and undifferentiated).
Smoking StatusBaseline to week 26 follow upMeasured by self report and carbon monoxide breath test
Salt ConsumptionBaseline to week 26 follow upAssessed using 1 question from the Canadian Community Health Survey (2015) that assess weekly intake of salty foods.
Medication AdherenceBaseline to week 26 follow upAssessed through two questions asking whether or not participants ever forget to take their medication and if they ever stop taking their medication (if so why).
Physical ActivityBaseline to week 26 follow upMeasured through self reported physical activity

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026